Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis
- 27 April 2001
- journal article
- review article
- Published by SAGE Publications in Cardiovascular Surgery
- Vol. 9 (3) , 211-218
- https://doi.org/10.1016/s0967-2109(00)00144-7
Abstract
Objective: To review the current research and published literature regarding the development of oral heparin therapy for the prophylaxis and treatment of deep venous thrombosis.Keywords
This publication has 14 references indexed in Scilit:
- Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.Circulation, 2000
- Oral low–molecular weight heparin and delivery agent prevents jugular venous thrombosis in the ratJournal of Vascular Surgery, 1999
- Acute Pulmonary ThromboembolismCirculation, 1999
- Orally administered heparin for preventing deep venous thrombosisThe American Journal of Surgery, 1998
- Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations.Pharmaceutical Research, 1997
- History of drugs for thrombotic disease. Discovery, development, and directions for the future.Circulation, 1994
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1992
- HeparinNew England Journal of Medicine, 1991
- A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT StudyArchives of internal medicine (1960), 1991
- Pharmacology of heparin and warfarinJournal of the American College of Cardiology, 1986